*BENZ schreef:
GTCB moet voor het eind van deze maand een beurswaarde hebben van 50 miljoen anders riskeren ze delisting. Er staan 102M aandelen uit dus dat houd in dat een aandeel zo'n 50 cent moet zijn om aan deze beurswaarde te komen.
Ik denk dat GTCB er zelf alles aan zal doen om dit te halen. Wellicht laten ze zelf een zooitje aandelen inkopen.
Zie onderstaand bericht:
GTC Biotherapeutics Inc. is trying to stop being delisted from the NASDAQ Global Market.
Since receiving a warning notice in January, the Framingham, Mass. company (NASDAQ: GTCB) hasn’t been able to boost its stock price to the minimum of $1 required under NASDAQ rules.
The time to comply with the warning letter ran out on July 15, which means GTC may be delisted.
The company, however, plans to request a hearing intended to fight such an action, so delisting will be delayed until after a NASDAQ panel can be convened and make a determination.
That’s not the only trouble facing GTC. The company also received a warning letter over its market value, which has fallen below the minimum $50 million requirement. If it can’t gain compliance on this point by July 31, GTC will also address this issue at the expected NASDAQ panel hearing.
GTC’s stock traded at 36 cents early on Monday and its market cap was just over $37 million.